Drugs

FDA Webinar: Webinar Draft GFI On Rheumatoid Arthritis - Developing Drug Products For Treatment; Availability – July 25, 2013

On July 25, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance For Industry On Rheumatoid Arthritis - Developing Drug Products For Treatment; Availability."

 
The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It was also intended to encourage the submission of questions or comments while the guidance is still in draft form.
 
Questions may be submitted to docket so that they can be formally processed by FDA.
 
DRAFT GFI:
 
FR NOTICE
 
Date FR NOA: 05/31/2013
Comment Period Closes: 07/30/2013
 
CONTACTS:
Nikolay Nikolov, MD
Medical Officer
Division Of Pulmonary, Allergy, And Rheumatology Products
Center for Drug Evaluation and Research (CDER)
White Oak, Bldg 22, Room 3335
301-796-5281

Presentation Information

Archive of Past Webinars: http://www.fda.gov/Training/GuidanceWebinars/default.htm   

 
If you have never attended a Connect Pro meeting before, please test your connection before the lecture by following this link: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm

More in Drugs

Resources for You

Page Last Updated: 10/08/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English